Nickolas Zaller
Concepts (347)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
HIV Infections | 61 | 2024 | 354 | 10.650 |
Why?
| Prisoners | 34 | 2022 | 87 | 6.920 |
Why?
| Substance Abuse, Intravenous | 23 | 2020 | 43 | 5.720 |
Why?
| Opioid-Related Disorders | 21 | 2024 | 375 | 5.200 |
Why?
| Prisons | 24 | 2022 | 38 | 4.310 |
Why?
| Opiate Substitution Treatment | 12 | 2022 | 83 | 3.610 |
Why?
| Analgesics, Opioid | 18 | 2022 | 532 | 3.550 |
Why?
| Substance-Related Disorders | 26 | 2022 | 595 | 3.440 |
Why?
| Hepatitis C | 11 | 2021 | 77 | 3.080 |
Why?
| Homosexuality, Male | 20 | 2024 | 49 | 3.070 |
Why?
| Methadone | 13 | 2020 | 172 | 2.770 |
Why?
| Health Services Accessibility | 13 | 2024 | 392 | 2.670 |
Why?
| Patient Acceptance of Health Care | 12 | 2024 | 327 | 2.210 |
Why?
| Risk-Taking | 16 | 2020 | 109 | 2.180 |
Why?
| Buprenorphine | 8 | 2024 | 134 | 2.060 |
Why?
| Humans | 150 | 2024 | 49827 | 1.990 |
Why?
| Adult | 83 | 2024 | 13160 | 1.990 |
Why?
| Bisexuality | 6 | 2018 | 14 | 1.910 |
Why?
| Criminal Law | 10 | 2021 | 30 | 1.810 |
Why?
| Mass Screening | 12 | 2020 | 351 | 1.800 |
Why?
| Health Knowledge, Attitudes, Practice | 15 | 2022 | 488 | 1.780 |
Why?
| Telemedicine | 7 | 2024 | 443 | 1.770 |
Why?
| Syringes | 6 | 2014 | 13 | 1.720 |
Why?
| Rhode Island | 26 | 2018 | 28 | 1.710 |
Why?
| Naloxone | 9 | 2016 | 77 | 1.700 |
Why?
| Harm Reduction | 4 | 2020 | 7 | 1.690 |
Why?
| Methamphetamine | 3 | 2024 | 200 | 1.540 |
Why?
| Sexual Behavior | 12 | 2022 | 116 | 1.530 |
Why?
| Hepacivirus | 8 | 2021 | 103 | 1.530 |
Why?
| Male | 90 | 2024 | 25093 | 1.520 |
Why?
| Drug Overdose | 13 | 2020 | 158 | 1.520 |
Why?
| United States | 36 | 2024 | 4838 | 1.450 |
Why?
| Alcohol Drinking | 8 | 2017 | 223 | 1.430 |
Why?
| Young Adult | 37 | 2024 | 3936 | 1.410 |
Why?
| Pharmacists | 7 | 2014 | 144 | 1.390 |
Why?
| Pharmacies | 6 | 2014 | 61 | 1.360 |
Why?
| Rural Population | 8 | 2022 | 535 | 1.350 |
Why?
| Health Status Disparities | 6 | 2021 | 195 | 1.340 |
Why?
| Needle-Exchange Programs | 5 | 2020 | 5 | 1.340 |
Why?
| Female | 76 | 2024 | 26329 | 1.330 |
Why?
| Prevalence | 23 | 2022 | 943 | 1.330 |
Why?
| Mental Disorders | 10 | 2022 | 389 | 1.300 |
Why?
| Middle Aged | 48 | 2022 | 11997 | 1.270 |
Why?
| Attitude of Health Personnel | 6 | 2017 | 348 | 1.260 |
Why?
| Anti-HIV Agents | 4 | 2022 | 42 | 1.210 |
Why?
| Amphetamine-Related Disorders | 4 | 2024 | 94 | 1.180 |
Why?
| Unsafe Sex | 8 | 2020 | 26 | 1.160 |
Why?
| Healthcare Disparities | 3 | 2023 | 258 | 1.150 |
Why?
| Sexually Transmitted Diseases | 7 | 2016 | 36 | 1.120 |
Why?
| Minority Groups | 7 | 2022 | 132 | 1.110 |
Why?
| Socioeconomic Factors | 19 | 2021 | 580 | 1.040 |
Why?
| China | 19 | 2024 | 87 | 1.000 |
Why?
| Cross-Sectional Studies | 23 | 2023 | 1541 | 0.980 |
Why?
| Continuity of Patient Care | 3 | 2017 | 53 | 0.970 |
Why?
| Criminals | 4 | 2020 | 23 | 0.970 |
Why?
| Alcoholism | 4 | 2021 | 232 | 0.930 |
Why?
| Urban Population | 3 | 2021 | 151 | 0.920 |
Why?
| Adolescent | 31 | 2022 | 6340 | 0.910 |
Why?
| Delivery of Health Care | 5 | 2023 | 307 | 0.890 |
Why?
| Pandemics | 6 | 2024 | 554 | 0.860 |
Why?
| Narcotic Antagonists | 10 | 2018 | 130 | 0.850 |
Why?
| Mental Health Services | 3 | 2023 | 194 | 0.850 |
Why?
| Mental Health | 2 | 2023 | 216 | 0.850 |
Why?
| Urinary Bladder Diseases | 1 | 2022 | 18 | 0.830 |
Why?
| Community Pharmacy Services | 3 | 2014 | 68 | 0.830 |
Why?
| Research | 1 | 2022 | 112 | 0.820 |
Why?
| Transients and Migrants | 4 | 2015 | 24 | 0.820 |
Why?
| Influenza Vaccines | 1 | 2022 | 31 | 0.810 |
Why?
| Yoga | 1 | 2020 | 17 | 0.740 |
Why?
| Substance Abuse Treatment Centers | 5 | 2024 | 76 | 0.730 |
Why?
| Public Health | 5 | 2022 | 200 | 0.720 |
Why?
| Health Services | 3 | 2011 | 67 | 0.670 |
Why?
| Heterosexuality | 4 | 2015 | 9 | 0.660 |
Why?
| Health Personnel | 2 | 2022 | 241 | 0.650 |
Why?
| Prescription Drug Misuse | 3 | 2015 | 31 | 0.650 |
Why?
| Racism | 1 | 2020 | 56 | 0.640 |
Why?
| Rural Health Services | 1 | 2020 | 164 | 0.630 |
Why?
| Sexual Partners | 8 | 2021 | 28 | 0.610 |
Why?
| Arkansas | 9 | 2022 | 1967 | 0.610 |
Why?
| Feasibility Studies | 5 | 2024 | 374 | 0.600 |
Why?
| Community Integration | 1 | 2017 | 1 | 0.600 |
Why?
| Pneumonia, Viral | 1 | 2020 | 168 | 0.590 |
Why?
| Coronavirus Infections | 1 | 2020 | 178 | 0.580 |
Why?
| Social Stigma | 1 | 2017 | 47 | 0.580 |
Why?
| Multivariate Analysis | 8 | 2021 | 585 | 0.570 |
Why?
| Health Policy | 3 | 2015 | 153 | 0.570 |
Why?
| Social Class | 1 | 2017 | 94 | 0.560 |
Why?
| Sexuality | 2 | 2016 | 13 | 0.560 |
Why?
| Workplace | 2 | 2015 | 94 | 0.550 |
Why?
| Drug Users | 3 | 2016 | 18 | 0.550 |
Why?
| Risk Factors | 19 | 2022 | 3619 | 0.550 |
Why?
| Health Literacy | 1 | 2018 | 129 | 0.550 |
Why?
| Social Justice | 2 | 2022 | 24 | 0.540 |
Why?
| Crime | 3 | 2020 | 25 | 0.530 |
Why?
| Minority Health | 1 | 2015 | 10 | 0.520 |
Why?
| HIV Seropositivity | 2 | 2013 | 26 | 0.520 |
Why?
| HIV | 4 | 2018 | 24 | 0.520 |
Why?
| Condoms | 7 | 2019 | 22 | 0.520 |
Why?
| Pilot Projects | 6 | 2024 | 699 | 0.510 |
Why?
| Qualitative Research | 5 | 2022 | 325 | 0.500 |
Why?
| Blood Donors | 2 | 2006 | 31 | 0.490 |
Why?
| Case Management | 3 | 2015 | 43 | 0.460 |
Why?
| Heroin Dependence | 6 | 2018 | 45 | 0.460 |
Why?
| Aged | 12 | 2022 | 9272 | 0.410 |
Why?
| Logistic Models | 8 | 2015 | 891 | 0.400 |
Why?
| Pain | 1 | 2015 | 380 | 0.400 |
Why?
| Ambulatory Care | 3 | 2018 | 222 | 0.400 |
Why?
| Confined Spaces | 3 | 2018 | 4 | 0.390 |
Why?
| Equipment Contamination | 2 | 2010 | 18 | 0.390 |
Why?
| Attitude to Health | 2 | 2011 | 191 | 0.380 |
Why?
| Comorbidity | 7 | 2021 | 618 | 0.370 |
Why?
| Medicaid | 3 | 2022 | 257 | 0.370 |
Why?
| Patient Discharge | 3 | 2021 | 322 | 0.370 |
Why?
| Hepatitis, Viral, Human | 2 | 2010 | 6 | 0.360 |
Why?
| Interviews as Topic | 5 | 2020 | 258 | 0.360 |
Why?
| Contraceptives, Postcoital | 1 | 2010 | 1 | 0.360 |
Why?
| Behind-the-Counter Drugs | 1 | 2010 | 1 | 0.360 |
Why?
| Contraception, Postcoital | 1 | 2009 | 8 | 0.350 |
Why?
| Methicillin-Resistant Staphylococcus aureus | 1 | 2010 | 76 | 0.340 |
Why?
| Judicial Role | 2 | 2018 | 6 | 0.340 |
Why?
| Prescription Drugs | 3 | 2014 | 38 | 0.330 |
Why?
| Disease Outbreaks | 2 | 2009 | 125 | 0.320 |
Why?
| Health Promotion | 2 | 2023 | 271 | 0.320 |
Why?
| Self Report | 3 | 2020 | 192 | 0.320 |
Why?
| Program Evaluation | 3 | 2020 | 349 | 0.320 |
Why?
| Ukraine | 2 | 2020 | 5 | 0.310 |
Why?
| Self Care | 2 | 2019 | 135 | 0.310 |
Why?
| Staphylococcal Infections | 1 | 2010 | 269 | 0.300 |
Why?
| Anti-Retroviral Agents | 2 | 2020 | 14 | 0.300 |
Why?
| Forensic Psychiatry | 1 | 2007 | 6 | 0.300 |
Why?
| Narcotics | 4 | 2013 | 111 | 0.290 |
Why?
| Motivation | 3 | 2022 | 273 | 0.290 |
Why?
| Alcohol-Related Disorders | 3 | 2015 | 44 | 0.280 |
Why?
| Cocaine-Related Disorders | 3 | 2017 | 205 | 0.270 |
Why?
| Substance Withdrawal Syndrome | 3 | 2018 | 168 | 0.260 |
Why?
| Stress Disorders, Post-Traumatic | 2 | 2022 | 357 | 0.260 |
Why?
| Police | 2 | 2016 | 4 | 0.250 |
Why?
| Nutrition Surveys | 2 | 2015 | 104 | 0.250 |
Why?
| Blood Transfusion | 1 | 2006 | 121 | 0.250 |
Why?
| Severity of Illness Index | 4 | 2021 | 942 | 0.240 |
Why?
| Sex Factors | 4 | 2017 | 693 | 0.230 |
Why?
| Hospitals, Psychiatric | 1 | 2023 | 15 | 0.230 |
Why?
| Vaccination | 2 | 2022 | 268 | 0.220 |
Why?
| Hepatitis C, Chronic | 2 | 2016 | 82 | 0.210 |
Why?
| Law Enforcement | 3 | 2022 | 10 | 0.210 |
Why?
| Infection Control | 2 | 2020 | 50 | 0.200 |
Why?
| Crisis Intervention | 1 | 2021 | 10 | 0.200 |
Why?
| Ownership | 1 | 2021 | 17 | 0.200 |
Why?
| Housing | 1 | 2022 | 46 | 0.200 |
Why?
| Suicide | 1 | 2022 | 74 | 0.200 |
Why?
| Drug Monitoring | 2 | 2012 | 77 | 0.200 |
Why?
| Community Health Workers | 1 | 2022 | 43 | 0.200 |
Why?
| Baltimore | 2 | 2020 | 29 | 0.200 |
Why?
| Geography | 1 | 2021 | 61 | 0.190 |
Why?
| Incidence | 4 | 2019 | 1003 | 0.190 |
Why?
| Masks | 1 | 2021 | 30 | 0.190 |
Why?
| Wounds, Gunshot | 1 | 2021 | 30 | 0.190 |
Why?
| Patient Protection and Affordable Care Act | 1 | 2021 | 51 | 0.190 |
Why?
| Southeastern United States | 1 | 2020 | 45 | 0.180 |
Why?
| Follow-Up Studies | 6 | 2018 | 2179 | 0.180 |
Why?
| Awareness | 1 | 2020 | 29 | 0.180 |
Why?
| Geriatrics | 1 | 2021 | 46 | 0.180 |
Why?
| Needle Sharing | 2 | 2012 | 3 | 0.180 |
Why?
| Models, Theoretical | 1 | 2021 | 174 | 0.180 |
Why?
| Primary Health Care | 1 | 2024 | 353 | 0.180 |
Why?
| Knowledge | 1 | 2020 | 28 | 0.180 |
Why?
| Chronic Pain | 1 | 2022 | 161 | 0.180 |
Why?
| Kenya | 1 | 2019 | 11 | 0.170 |
Why?
| Prejudice | 1 | 2020 | 39 | 0.170 |
Why?
| Pharmaceutical Preparations | 1 | 2020 | 76 | 0.170 |
Why?
| Universities | 1 | 2020 | 156 | 0.170 |
Why?
| Emergency Service, Hospital | 2 | 2014 | 488 | 0.170 |
Why?
| Reproducibility of Results | 1 | 2022 | 1188 | 0.170 |
Why?
| Hospitals | 2 | 2021 | 175 | 0.160 |
Why?
| Reproductive Health | 2 | 2015 | 8 | 0.160 |
Why?
| Demography | 2 | 2018 | 93 | 0.160 |
Why?
| Puerto Rico | 1 | 2018 | 15 | 0.160 |
Why?
| Survival Rate | 1 | 2021 | 905 | 0.160 |
Why?
| Health Behavior | 2 | 2018 | 251 | 0.160 |
Why?
| Mouth | 1 | 2018 | 33 | 0.160 |
Why?
| Smoking | 1 | 2022 | 510 | 0.160 |
Why?
| Pennsylvania | 2 | 2016 | 26 | 0.150 |
Why?
| Stress, Psychological | 2 | 2022 | 260 | 0.150 |
Why?
| Health Status | 1 | 2020 | 298 | 0.150 |
Why?
| Sex Distribution | 2 | 2015 | 135 | 0.150 |
Why?
| Office Visits | 1 | 2018 | 41 | 0.150 |
Why?
| Age Distribution | 2 | 2015 | 170 | 0.150 |
Why?
| Naltrexone | 1 | 2018 | 58 | 0.150 |
Why?
| Longitudinal Studies | 5 | 2020 | 673 | 0.150 |
Why?
| Emigrants and Immigrants | 1 | 2018 | 35 | 0.150 |
Why?
| Age Factors | 3 | 2018 | 1090 | 0.150 |
Why?
| Referral and Consultation | 4 | 2022 | 287 | 0.150 |
Why?
| Massachusetts | 3 | 2012 | 25 | 0.150 |
Why?
| Binge Drinking | 1 | 2017 | 24 | 0.140 |
Why?
| Biomedical Research | 1 | 2020 | 231 | 0.140 |
Why?
| Hepatitis C Antibodies | 1 | 2016 | 20 | 0.140 |
Why?
| Cohort Studies | 3 | 2018 | 1422 | 0.140 |
Why?
| Health Care Surveys | 3 | 2013 | 174 | 0.140 |
Why?
| Drug Administration Schedule | 2 | 2015 | 376 | 0.140 |
Why?
| Education | 1 | 2016 | 41 | 0.130 |
Why?
| Connecticut | 5 | 2013 | 15 | 0.130 |
Why?
| Depression | 2 | 2018 | 564 | 0.130 |
Why?
| Cooperative Behavior | 2 | 2017 | 223 | 0.130 |
Why?
| Medication Adherence | 2 | 2013 | 126 | 0.130 |
Why?
| Education, Medical, Continuing | 1 | 2016 | 68 | 0.130 |
Why?
| Homosexuality, Female | 1 | 2015 | 7 | 0.130 |
Why?
| Abortion, Induced | 1 | 2015 | 19 | 0.130 |
Why?
| Health Services Needs and Demand | 2 | 2013 | 158 | 0.130 |
Why?
| Ambulatory Care Facilities | 1 | 2016 | 125 | 0.130 |
Why?
| Cocaine | 1 | 2016 | 169 | 0.130 |
Why?
| Community Health Centers | 1 | 2015 | 29 | 0.120 |
Why?
| Prescriptions | 2 | 2014 | 10 | 0.120 |
Why?
| Health Surveys | 2 | 2013 | 232 | 0.120 |
Why?
| Nonprescription Drugs | 2 | 2014 | 37 | 0.120 |
Why?
| Pain Measurement | 1 | 2015 | 236 | 0.120 |
Why?
| Coercion | 1 | 2013 | 6 | 0.110 |
Why?
| Utilization Review | 1 | 2013 | 30 | 0.110 |
Why?
| Pain Management | 1 | 2015 | 146 | 0.110 |
Why?
| Syphilis | 1 | 2013 | 25 | 0.110 |
Why?
| Neoplasms | 1 | 2023 | 1233 | 0.110 |
Why?
| Statistics as Topic | 1 | 2013 | 89 | 0.110 |
Why?
| Carcinoma, Hepatocellular | 1 | 2016 | 194 | 0.110 |
Why?
| Attitude | 1 | 2013 | 69 | 0.110 |
Why?
| Behavior, Addictive | 1 | 2013 | 58 | 0.110 |
Why?
| Time Factors | 3 | 2018 | 2912 | 0.110 |
Why?
| Clinical Pharmacy Information Systems | 1 | 2012 | 3 | 0.110 |
Why?
| AIDS Serodiagnosis | 2 | 2015 | 9 | 0.110 |
Why?
| Drug Utilization | 2 | 2010 | 78 | 0.110 |
Why?
| Pharmaceutical Services | 1 | 2013 | 55 | 0.100 |
Why?
| Organizational Policy | 1 | 2012 | 40 | 0.100 |
Why?
| Community Health Services | 1 | 2013 | 101 | 0.100 |
Why?
| Health Care Costs | 2 | 2010 | 170 | 0.100 |
Why?
| Heroin | 1 | 2012 | 13 | 0.100 |
Why?
| Data Collection | 2 | 2011 | 279 | 0.100 |
Why?
| Liver Neoplasms | 1 | 2016 | 332 | 0.100 |
Why?
| Antiretroviral Therapy, Highly Active | 2 | 2014 | 34 | 0.100 |
Why?
| Emergency Medical Technicians | 1 | 2011 | 10 | 0.100 |
Why?
| Alcoholic Intoxication | 1 | 2011 | 19 | 0.100 |
Why?
| Academic Medical Centers | 2 | 2009 | 132 | 0.100 |
Why?
| Patient Compliance | 1 | 2013 | 230 | 0.100 |
Why?
| Retrospective Studies | 3 | 2019 | 6117 | 0.090 |
Why?
| Methicillin Resistance | 1 | 2010 | 17 | 0.090 |
Why?
| Policy | 1 | 2010 | 24 | 0.090 |
Why?
| Confidence Intervals | 1 | 2010 | 156 | 0.090 |
Why?
| Commerce | 1 | 2010 | 43 | 0.090 |
Why?
| Hepatitis B | 2 | 2007 | 23 | 0.090 |
Why?
| Aged, 80 and over | 2 | 2015 | 3125 | 0.090 |
Why?
| Contraception Behavior | 1 | 2009 | 10 | 0.090 |
Why?
| Recurrence | 2 | 2013 | 651 | 0.090 |
Why?
| Blood-Borne Pathogens | 2 | 2007 | 7 | 0.090 |
Why?
| Interpersonal Relations | 1 | 2010 | 102 | 0.080 |
Why?
| Odds Ratio | 1 | 2010 | 548 | 0.080 |
Why?
| Veterans | 1 | 2015 | 550 | 0.080 |
Why?
| Communicable Diseases | 1 | 2009 | 55 | 0.080 |
Why?
| Disease Transmission, Infectious | 2 | 2006 | 13 | 0.080 |
Why?
| Self Efficacy | 2 | 2021 | 128 | 0.080 |
Why?
| Ohio | 2 | 2018 | 40 | 0.080 |
Why?
| Kentucky | 2 | 2018 | 47 | 0.080 |
Why?
| Diagnostic Services | 1 | 2007 | 3 | 0.070 |
Why?
| Equipment Reuse | 1 | 2007 | 2 | 0.070 |
Why?
| Substance Abuse Detection | 1 | 2007 | 92 | 0.070 |
Why?
| Vaccines, Combined | 1 | 2007 | 2 | 0.070 |
Why?
| Hepatitis A Vaccines | 1 | 2007 | 2 | 0.070 |
Why?
| Hepatitis A | 1 | 2007 | 4 | 0.070 |
Why?
| Hepatitis B Vaccines | 1 | 2007 | 4 | 0.070 |
Why?
| Urban Health Services | 1 | 2007 | 21 | 0.070 |
Why?
| Treatment Outcome | 4 | 2013 | 5138 | 0.070 |
Why?
| Risk Reduction Behavior | 2 | 2018 | 59 | 0.070 |
Why?
| Public Health Administration | 1 | 2007 | 81 | 0.070 |
Why?
| Health Expenditures | 1 | 2007 | 67 | 0.070 |
Why?
| Vulnerable Populations | 2 | 2017 | 45 | 0.060 |
Why?
| Survival Analysis | 1 | 2006 | 659 | 0.060 |
Why?
| Prospective Studies | 3 | 2018 | 2344 | 0.060 |
Why?
| Georgia (Republic) | 1 | 2004 | 2 | 0.060 |
Why?
| Cities | 1 | 2024 | 18 | 0.060 |
Why?
| Counseling | 2 | 2016 | 133 | 0.060 |
Why?
| Education, Pharmacy, Continuing | 2 | 2014 | 4 | 0.060 |
Why?
| Educational Status | 2 | 2015 | 222 | 0.060 |
Why?
| Public Health Surveillance | 1 | 2022 | 13 | 0.050 |
Why?
| New England | 2 | 2013 | 10 | 0.050 |
Why?
| Intention | 1 | 2023 | 43 | 0.050 |
Why?
| Jurisprudence | 1 | 2022 | 11 | 0.050 |
Why?
| Genotype | 2 | 2016 | 538 | 0.050 |
Why?
| Quarantine | 1 | 2022 | 13 | 0.050 |
Why?
| Insurance Coverage | 1 | 2022 | 102 | 0.050 |
Why?
| Costs and Cost Analysis | 1 | 2021 | 95 | 0.050 |
Why?
| Influenza, Human | 1 | 2022 | 85 | 0.050 |
Why?
| Medicare | 1 | 2022 | 244 | 0.050 |
Why?
| Violence | 1 | 2021 | 62 | 0.050 |
Why?
| Linear Models | 1 | 2021 | 281 | 0.050 |
Why?
| Safe Sex | 1 | 2019 | 10 | 0.040 |
Why?
| Serologic Tests | 1 | 2019 | 27 | 0.040 |
Why?
| Delayed-Action Preparations | 1 | 2018 | 47 | 0.040 |
Why?
| Chronic Disease | 1 | 2020 | 563 | 0.040 |
Why?
| Crack Cocaine | 1 | 2017 | 17 | 0.040 |
Why?
| Random Allocation | 1 | 2018 | 280 | 0.040 |
Why?
| Hepatitis B Antibodies | 1 | 2016 | 6 | 0.030 |
Why?
| Outpatients | 1 | 2017 | 113 | 0.030 |
Why?
| Quality of Life | 1 | 2022 | 833 | 0.030 |
Why?
| Health Education | 2 | 2007 | 156 | 0.030 |
Why?
| Needs Assessment | 1 | 2016 | 133 | 0.030 |
Why?
| Regression Analysis | 1 | 2016 | 395 | 0.030 |
Why?
| Cultural Characteristics | 1 | 2015 | 22 | 0.030 |
Why?
| Adult Survivors of Child Abuse | 1 | 2015 | 20 | 0.030 |
Why?
| Child Abuse, Sexual | 1 | 2015 | 32 | 0.030 |
Why?
| Polymerase Chain Reaction | 1 | 2016 | 455 | 0.030 |
Why?
| Employment | 1 | 2015 | 90 | 0.030 |
Why?
| Mexico | 1 | 2014 | 36 | 0.030 |
Why?
| Treponema pallidum | 1 | 2013 | 10 | 0.030 |
Why?
| Hospital Rapid Response Team | 1 | 2013 | 2 | 0.030 |
Why?
| Social Environment | 1 | 2014 | 80 | 0.030 |
Why?
| Social Adjustment | 1 | 2013 | 29 | 0.030 |
Why?
| Social Work | 1 | 2013 | 25 | 0.030 |
Why?
| Professional Role | 1 | 2014 | 76 | 0.030 |
Why?
| Epidemics | 1 | 2013 | 19 | 0.030 |
Why?
| Coinfection | 1 | 2013 | 38 | 0.030 |
Why?
| Empathy | 1 | 2013 | 46 | 0.030 |
Why?
| Poverty | 1 | 2015 | 201 | 0.030 |
Why?
| Risk Assessment | 1 | 2018 | 1262 | 0.030 |
Why?
| Antibodies, Viral | 1 | 2013 | 88 | 0.030 |
Why?
| Electronic Prescribing | 1 | 2012 | 4 | 0.030 |
Why?
| Program Development | 1 | 2013 | 166 | 0.030 |
Why?
| Emergency Medical Services | 1 | 2013 | 111 | 0.030 |
Why?
| Insurance, Health | 1 | 2013 | 127 | 0.030 |
Why?
| Drug Prescriptions | 1 | 2013 | 95 | 0.030 |
Why?
| Disease Progression | 1 | 2015 | 822 | 0.030 |
Why?
| Case-Control Studies | 1 | 2015 | 1128 | 0.020 |
Why?
| Injections, Intravenous | 1 | 2012 | 140 | 0.020 |
Why?
| Philadelphia | 1 | 2011 | 12 | 0.020 |
Why?
| Triage | 1 | 2011 | 64 | 0.020 |
Why?
| Risk | 1 | 2012 | 320 | 0.020 |
Why?
| Interferon-alpha | 1 | 2010 | 47 | 0.020 |
Why?
| Community-Institutional Relations | 1 | 2010 | 46 | 0.020 |
Why?
| Polyethylene Glycols | 1 | 2010 | 96 | 0.020 |
Why?
| Preventive Health Services | 1 | 2010 | 51 | 0.020 |
Why?
| Evidence-Based Practice | 1 | 2010 | 96 | 0.020 |
Why?
| Drug Therapy, Combination | 1 | 2010 | 378 | 0.020 |
Why?
| Recombinant Proteins | 1 | 2010 | 486 | 0.020 |
Why?
| Antiviral Agents | 1 | 2010 | 174 | 0.020 |
Why?
| Child | 1 | 2021 | 6824 | 0.020 |
Why?
| New York City | 1 | 2008 | 26 | 0.020 |
Why?
| Acquired Immunodeficiency Syndrome | 1 | 2008 | 54 | 0.020 |
Why?
| HIV Seroprevalence | 1 | 2007 | 4 | 0.020 |
Why?
| Cost of Illness | 1 | 2007 | 117 | 0.020 |
Why?
| Causality | 1 | 2006 | 44 | 0.020 |
Why?
| Health Services Research | 1 | 2007 | 150 | 0.020 |
Why?
| Pregnancy | 1 | 2009 | 2584 | 0.010 |
Why?
|
|
Zaller's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|